Kv1.3
Meet in Italy for Life Sciences - Awards

We are happy and thrilled to announce that our Kv1.3 pitch was chosen as "Best Innovative Business Proposal" by a board of investors on Startup Breeding, an annual event of Cluster Nazionale Scienze della Vita ALISEI, the Italian National Cluster for Life Sciences.

Furthermore, we received the Special Awards of 2i3T - Innovative Companies Incubator of the University of Turin and Bioindustry Park Silvano Fumero S.p.A. Società Benefit.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 2, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 2, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life